These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7590785)

  • 21. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120.
    Thiriart C; Francotte M; Cohen J; Collignon C; Delers A; Kummert S; Molitor C; Gilles D; Roelants P; van Wijnendaele F
    J Immunol; 1989 Sep; 143(6):1832-6. PubMed ID: 2476484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.
    Corbet S; Vinner L; Hougaard DM; Bryder K; Nielsen HV; Nielsen C; Fomsgaard A
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1997-2008. PubMed ID: 11153083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of long-lived neutralizing antibodies to HIV-1 IIIB in mice with a vaccinia recombinant virus-infected cell vaccine expressing gp160.
    Parry C; McLain L; Dimmock NJ
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):205-12. PubMed ID: 8198873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal idiotypic and anti-idiotypic antibodies to human immunodeficiency virus type 1 envelope glycoprotein.
    Brodeur BR; Faucher S; O'Shaughnessy MV; Hamel J
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():51-8. PubMed ID: 1703562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins.
    Traincard F; Rey-Cuillé MA; Huon I; Dartevelle S; Mazié JC; Benichou S
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1659-67. PubMed ID: 7888225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160.
    Hu SL; Klaniecki J; Dykers T; Sridhar P; Travis BM
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):615-20. PubMed ID: 1768463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hybridoma producing human monoclonal antibody specific for glycoprotein 120 kDa of human immunodeficiency virus (HIV-1.
    Lake D; Sugano T; Matsumoto Y; Masuho Y; Petersen EA; Feorino P; Hersh EM
    Life Sci; 1989; 45(16):iii-x. PubMed ID: 2554084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Leu3a induces combining site-related anti-idiotypic antibody without inducing anti-HIV activity.
    Reeves JP; Buck D; Berkower I; Murphy D; Epstein SL
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):55-63. PubMed ID: 2015115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
    Gorse GJ; Corey L; Patel GB; Mandava M; Hsieh RH; Matthews TJ; Walker MC; McElrath MJ; Berman PW; Eibl MM; Belshe RB
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):115-32. PubMed ID: 10029244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A structure-based approach to a synthetic vaccine for HIV-1.
    Cabezas E; Wang M; Parren PW; Stanfield RL; Satterthwait AC
    Biochemistry; 2000 Nov; 39(47):14377-91. PubMed ID: 11087390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
    Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
    J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.
    Otteken A; Earl PL; Moss B
    J Virol; 1996 Jun; 70(6):3407-15. PubMed ID: 8648672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients.
    Oh SK; Cruikshank WW; Raina J; Blanchard GC; Adler WH; Walker J; Kornfeld H
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):251-6. PubMed ID: 1740750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
    Su H; Boackle RJ
    Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of monoclonal antibodies to native human immunodeficiency virus type 1 envelope glycoprotein by immunization of mice with naked RNA.
    Giraud A; Ataman-Onal Y; Battail N; Piga N; Brand D; Mandrand B; Verrier B
    J Virol Methods; 1999 Apr; 79(1):75-84. PubMed ID: 10328537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of human monoclonal antibodies against HIV-1 peptides.
    Bongertz V; Wigzell H; Rossi P
    Braz J Med Biol Res; 1991; 24(8):815-8. PubMed ID: 1797270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.